{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T02:09:57Z","timestamp":1784945397012,"version":"3.55.0"},"reference-count":98,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Epigallocatechin-3-gallate (EGCG), the major bioactive polyphenol in green tea, has garnered significant attention for its potential anticancer properties. This review summarizes the current evidence from in vitro, in vivo, and clinical trials examining the effects of EGCG on lung cancer. EGCG exerts its anticancer effects through various mechanisms, including the inhibition of cell proliferation, induction of apoptosis, suppression of metastasis, and modulation of signalling pathways such as epidermal growth factor receptor (EGFR), phosphoinositide 3-kinase\/protein kinase B (PI3K\/Akt), mitogen-activated protein kinase (MAPK), and nuclear factor kappa B (NF-\u03baB). Additionally, EGCG has been shown to enhance the efficacy of conventional chemotherapeutic agents and mitigate drug resistance. However, challenges related to its bioavailability and metabolic stability remain. Ultimately, this review aims to provide a comprehensive overview of the effects of EGCG against lung cancer.<\/jats:p>","DOI":"10.3390\/nu18030378","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T17:52:38Z","timestamp":1769190758000},"page":"378","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effects of Epigallocatechin Gallate Against Lung Cancer: Mechanisms of Action and Therapeutic Potential"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-4407-0194","authenticated-orcid":false,"given":"Dordaneh","family":"Mirbabaei Ghafghazi","sequence":"first","affiliation":[{"name":"Department of Health Sciences, Brock University, St. Catharines, ON L2S 3A1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5652-1687","authenticated-orcid":false,"given":"Newman Siu","family":"Kwan Sze","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Brock University, St. Catharines, ON L2S 3A1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4218-5851","authenticated-orcid":false,"given":"Evangelia","family":"Tsiani","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Brock University, St. Catharines, ON L2S 3A1, Canada"},{"name":"Centre for Bone and Muscle Health, Brock University, St. Catharines, ON L2S 3A1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Guo, Q., Liu, L., Chen, Z., Fan, Y., Zhou, Y., Yuan, Z., and Zhang, W. (2022). Current Treatments for Non-Small Cell Lung Cancer. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.945102"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12943-023-01740-y","article-title":"Lung Cancer Immunotherapy: Progress, Pitfalls, and Promises","volume":"22","author":"Lahiri","year":"2023","journal-title":"Mol. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1158\/1055-9965.EPI-19-0221","article-title":"Cancer Progress and Priorities: Lung Cancer","volume":"28","author":"Schabath","year":"2019","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Garg, P., Singhal, S., Kulkarni, P., Horne, D., Malhotra, J., Salgia, R., and Singhal, S.S. (2024). Advances in Non-Small Cell Lung Cancer: Current Insights and Future Directions. J. Clin. Med., 13.","DOI":"10.3390\/jcm13144189"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Bertelli, A., Biagi, M., Corsini, M., Baini, G., Cappellucci, G., and Miraldi, E. (2021). Polyphenols: From Theory to Practice. Foods, 10.","DOI":"10.3390\/foods10112595"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Niedzwiecki, A., Roomi, M.W., Kalinovsky, T., and Rath, M. (2016). Anticancer Efficacy of Polyphenols and Their Combinations. Nutrients, 8.","DOI":"10.3390\/nu8090552"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.phytochem.2006.06.020","article-title":"Epigallocatechin-3-Gallate (EGCG): Chemical and Biomedical Perspectives","volume":"67","author":"Nagle","year":"2006","journal-title":"Phytochemistry"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.imr.2013.12.001","article-title":"Anticancer Effects and Molecular Mechanisms of Epigallocatechin-3-Gallate","volume":"3","author":"Min","year":"2014","journal-title":"Integr. Med. Res."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Mokra, D., Joskova, M., and Mokry, J. (2022). Therapeutic Effects of Green Tea Polyphenol (\u2212)-Epigallocatechin-3-Gallate (EGCG) in Relation to Molecular Pathways Controlling Inflammation, Oxidative Stress, and Apoptosis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24010340"},{"key":"ref_10","first-page":"639","article-title":"Mechanisms of Growth Inhibition of Human Lung Cancer Cell Line, PC-9, by Tea Polyphenols","volume":"88","author":"Okabe","year":"1997","journal-title":"Cancer Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/carcin\/19.4.611","article-title":"Inhibition of Growth and Induction of Apoptosis in Human Cancer Cell Lines by Tea Polyphenols","volume":"19","author":"Yang","year":"1998","journal-title":"Carcinogenesis"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/carcin\/21.5.915","article-title":"(\u2212)-Epigallocatechin Gallate Can Prevent Cisplatin-Induced Lung Tumorigenesis in A\/J Mice","volume":"21","author":"Mimoto","year":"2000","journal-title":"Carcinogenesis"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbrc.2007.06.030","article-title":"The Green Tea Polyphenol, Epigallocatechin-3-Gallate Inhibits Telomerase and Induces Apoptosis in Drug-Resistant Lung Cancer Cells","volume":"360","author":"Sadava","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Bhardwaj, V., and Mandal, A.K.A. (2019). Next-Generation Sequencing Reveals the Role of Epigallocatechin-3-Gallate in Regulating Putative Novel and Known microRNAs Which Target the MAPK Pathway in Non-Small-Cell Lung Cancer A549 Cells. Molecules, 24.","DOI":"10.3390\/molecules24020368"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1158\/1078-0432.CCR-09-0109","article-title":"The Green Tea Polyphenol, EGCG, Potentiates the Anti-Proliferative Activity of c-Met and EGFR Inhibitors in Non-Small Cell Lung Cancer Cells","volume":"15","author":"Milligan","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3892\/or.2013.2933","article-title":"Epigallocatechin Gallate Inhibits the Growth of Human Lung Cancer by Directly Targeting the EGFR Signaling Pathway","volume":"31","author":"Ma","year":"2014","journal-title":"Oncol. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/carcin\/bgq039","article-title":"Pro-Oxidative Activities and Dose\u2013Response Relationship of (\u2212)-Epigallocatechin-3-Gallate in the Inhibition of Lung Cancer Cell Growth: A Comparative Study In Vivo and In Vitro","volume":"31","author":"Li","year":"2010","journal-title":"Carcinogenesis"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.7150\/ijbs.18830","article-title":"Metformin Sensitizes Non-Small Cell Lung Cancer Cells to an Epigallocatechin-3-Gallate (EGCG) Treatment by Suppressing the Nrf2\/HO-1 Signaling Pathway","volume":"13","author":"Yu","year":"2017","journal-title":"Int. J. Biol. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"12023","DOI":"10.3390\/ijms140612023","article-title":"Combination of Low Concentration of (\u2212)-Epigallocatechin Gallate (EGCG) and Curcumin Strongly Suppresses the Growth of Non-Small Cell Lung Cancer In Vitro and In Vivo through Causing Cell Cycle Arrest","volume":"14","author":"Zhou","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jnutbio.2016.12.015","article-title":"Down-Regulation of Histone Deacetylase 4, \u22125 and \u22126 as a Mechanism of Synergistic Enhancement of Apoptosis in Human Lung Cancer Cells Treated with the Combination of a Synthetic Retinoid, Am80 and Green Tea Catechin","volume":"42","author":"Oya","year":"2017","journal-title":"J. Nutr. Biochem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1080\/01635581.2014.894101","article-title":"EGCG Enhances the Efficacy of Cisplatin by Downregulating Hsa-miR-98-5p in NSCLC A549 Cells","volume":"66","author":"Zhou","year":"2014","journal-title":"Nutr. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.biopha.2014.12.016","article-title":"Green Tea Polyphenol EGCG Reverse Cisplatin Resistance of A549\/DDP Cell Line through Candidate Genes Demethylation","volume":"69","author":"Zhang","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.3892\/or.2016.4587","article-title":"EGCG Induces Lung Cancer A549 Cell Apoptosis by Regulating Ku70 Acetylation","volume":"35","author":"Li","year":"2016","journal-title":"Oncol. Rep."},{"key":"ref_24","first-page":"4557","article-title":"Study of EGCG Induced Apoptosis in Lung Cancer Cells by Inhibiting PI3K\/Akt Signaling Pathway","volume":"22","author":"Gu","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3892\/etm.2014.1719","article-title":"Green Tea Catechin, Epigallocatechin-3-Gallate, Attenuates the Cell Viability of Human Non-Small-Cell Lung Cancer A549 Cells via Reducing Bcl-xL Expression","volume":"8","author":"Sonoda","year":"2014","journal-title":"Exp. Ther. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/ijc.21809","article-title":"Green Tea Polyphenol Stimulates Cancer Preventive Effects of Celecoxib in Human Lung Cancer Cells by Upregulation of GADD153 Gene","volume":"119","author":"Suganuma","year":"2006","journal-title":"Int. J. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"34557","DOI":"10.1074\/jbc.M110.141135","article-title":"Enhanced Anti-Tumor Activity by the Combination of the Natural Compounds (\u2212)-Epigallocatechin-3-Gallate and Luteolin: Potential Role of P53","volume":"285","author":"Amin","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bbrc.2013.07.078","article-title":"Enhancement of (\u2212)-Epigallocatechin-3-Gallate and Theaflavin-3-3\u2032-Digallate Induced Apoptosis by Ascorbic Acid in Human Lung Adenocarcinoma SPC-A-1 Cells and Esophageal Carcinoma Eca-109 Cells via MAPK Pathways","volume":"438","author":"Gao","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"217304","DOI":"10.1155\/2015\/217304","article-title":"Epigallocatechin-3-Gallate Enhances the Therapeutic Effects of Leptomycin B on Human Lung Cancer A549 Cells","volume":"2015","author":"Cromie","year":"2015","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.tiv.2009.04.011","article-title":"Identification of Epigallocatechin-3-Gallate in Green Tea Polyphenols as a Potent Inducer of P53-Dependent Apoptosis in the Human Lung Cancer Cell Line A549","volume":"23","author":"Yamauchi","year":"2009","journal-title":"Toxicol. Vitr."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.3892\/or.2013.2343","article-title":"Epigallocatechin Gallate Promotes P53 Accumulation and Activity via the Inhibition of MDM2-Mediated P53 Ubiquitination in Human Lung Cancer Cells","volume":"29","author":"Jin","year":"2013","journal-title":"Oncol. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"43337","DOI":"10.18632\/oncotarget.9712","article-title":"NEAT1 Upregulates EGCG-Induced CTR1 to Enhance Cisplatin Sensitivity in Lung Cancer Cells","volume":"7","author":"Jiang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bbrc.2016.11.038","article-title":"Wnt\/\u03b2-Catenin Pathway Mediates (\u2212)-Epigallocatechin-3-Gallate (EGCG) Inhibition of Lung Cancer Stem Cells","volume":"482","author":"Zhu","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.bbrc.2018.07.105","article-title":"Nano-Chemotherapeutic Efficacy of (\u2212)-Epigallocatechin 3-Gallate Mediating Apoptosis in A549 cells: Involvement of Reactive Oxygen Species Mediated Nrf2\/Keap1signaling","volume":"503","author":"Velavan","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/prca.201500008","article-title":"Differential Proteomic Analysis Reveals That EGCG Inhibits HDGF and Activates Apoptosis to Increase the Sensitivity of Non-Small Cells Lung Cancer to Chemotherapy","volume":"10","author":"Marchat","year":"2016","journal-title":"Proteom. Clin. Appl."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/mc.22901","article-title":"EGCG Inhibits CSC-like Properties through Targeting miR-485\/CD44 Axis in A549-cisplatin Resistant Cells","volume":"57","author":"Jiang","year":"2018","journal-title":"Mol. Carcinog."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Relat, J., Blancafort, A., Oliveras, G., Cuf\u00ed, S., Haro, D., Marrero, P.F., and Puig, T. (2012). Different Fatty Acid Metabolism Effects of (\u2212)-Epigallocatechin-3-Gallate and C75 in Adenocarcinoma Lung Cancer. BMC Cancer, 12.","DOI":"10.1186\/1471-2407-12-280"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Minnelli, C., Cianfruglia, L., Laudadio, E., Mobbili, G., Galeazzi, R., and Armeni, T. (2021). Effect of Epigallocatechin-3-Gallate on EGFR Signaling and Migration in Non-Small Cell Lung Cancer. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222111833"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12935-019-0981-0","article-title":"(\u2212)-Epigallocatechin-3-Gallate Derivatives Combined with Cisplatin Exhibit Synergistic Inhibitory Effects on Non-Small-Cell Lung Cancer Cells","volume":"19","author":"Wang","year":"2019","journal-title":"Cancer Cell Int."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"108263","DOI":"10.1016\/j.bioorg.2025.108263","article-title":"Novel (\u2212)-Eigallocatechin-3-Gallate-Erlotinib Conjugates via Triazole Rings Inhibit Non-Small Cell Lung Cancer Cells through EGFR Signaling Pathway","volume":"157","author":"Zi","year":"2025","journal-title":"Bioorganic Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"110084","DOI":"10.1016\/j.cbi.2022.110084","article-title":"Dimeric-(\u2212)-Epigallocatechin-3-Gallate Inhibits the Proliferation of Lung Cancer Cells by Inhibiting the EGFR Signaling Pathway","volume":"365","author":"Sun","year":"2022","journal-title":"Chem.-Biol. Interact."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.2147\/IJN.S243657","article-title":"Enhanced Chemotherapeutic Efficacy of PLGA-Encapsulated Epigallocatechin Gallate (EGCG) Against Human Lung Cancer","volume":"15","author":"Zhang","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"6543","DOI":"10.7150\/jca.34285","article-title":"Synergistic Inhibition of Lung Cancer Cells by EGCG and NF-\u03baB Inhibitor BAY11-7082","volume":"10","author":"Zhang","year":"2019","journal-title":"J. Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4046\/trd.2014.76.3.114","article-title":"Schedule-Dependent Effect of Epigallocatechin-3-Gallate (EGCG) with Paclitaxel on H460 Cells","volume":"76","author":"Park","year":"2014","journal-title":"Tuberc. Respir. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"108546","DOI":"10.1016\/j.abb.2020.108546","article-title":"EGCG Sensitizes Chemotherapeutic-Induced Cytotoxicity by Targeting the ERK Pathway in Multiple Cancer Cell Lines","volume":"692","author":"Wei","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.2147\/OTT.S209441","article-title":"EGCG Overcomes Gefitinib Resistance by Inhibiting Autophagy and Augmenting Cell Death through Targeting ERK Phosphorylation in NSCLC","volume":"12","author":"Meng","year":"2019","journal-title":"OncoTargets Ther."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e22239","DOI":"10.1002\/ddr.22239","article-title":"EGCG Enhances Antitumor Effect of Apatinib in Nonsmall Cell Lung Cancer by Targeting VEGF Signaling to Inhibit Glycolysis","volume":"85","author":"Zhou","year":"2024","journal-title":"Drug Dev. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12935-024-03391-5","article-title":"Epigallocatechin Gallate Modulates Ferroptosis through Downregulation of tsRNA-13502 in Non-Small Cell Lung Cancer","volume":"24","author":"Wang","year":"2024","journal-title":"Cancer Cell Int."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"109416","DOI":"10.1016\/j.jnutbio.2023.109416","article-title":"EGCG Alleviates Obesity-Exacerbated Lung Cancer Progression by STAT1\/SLC7A11 Pathway and Gut Microbiota","volume":"120","author":"Li","year":"2023","journal-title":"J. Nutr. Biochem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.biopha.2005.01.004","article-title":"Repressions of MMP-9 Expression and NF-\u03baB Localization Are Involved in Inhibition of Lung Carcinoma 95-D Cell Invasion by (\u2212)-Epigallocatechin-3-Gallate","volume":"59","author":"Yang","year":"2005","journal-title":"Biomed. Pharmacother."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"13318","DOI":"10.1021\/jf204149c","article-title":"EGCG Inhibits the Invasion of Highly Invasive CL1-5 Lung Cancer Cells through Suppressing MMP-2 Expression via JNK Signaling and Induces G2\/M Arrest","volume":"59","author":"Deng","year":"2011","journal-title":"J. Agric. Food Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"9863","DOI":"10.1021\/jf303690x","article-title":"EGCG Inhibits Transforming Growth Factor-\u03b2-Mediated Epithelial-to-Mesenchymal Transition via the Inhibition of Smad2 and Erk1\/2 Signaling Pathways in Nonsmall Cell Lung Cancer Cells","volume":"60","author":"Liu","year":"2012","journal-title":"J. Agric. Food Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.canlet.2013.02.018","article-title":"TGF-\u03921-Induced Epithelial\u2013Mesenchymal Transition and Acetylation of Smad2 and Smad3 Are Negatively Regulated by EGCG in Human A549 Lung Cancer Cells","volume":"335","author":"Ko","year":"2013","journal-title":"Cancer Lett."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.3892\/or.2015.3889","article-title":"Epigallocatechin-3-Gallate Inhibits Nicotine-Induced Migration and Invasion by the Suppression of Angiogenesis and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer Cells","volume":"33","author":"Shi","year":"2015","journal-title":"Oncol. Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2013.10.094","article-title":"Mechanism-Based Inhibition of Cancer Metastasis with (\u2212)-Epigallocatechin Gallate","volume":"443","author":"Takahashi","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1038\/s41598-020-62136-2","article-title":"Anticancer Effects of Epigallocatechin-3-Gallate Nanoemulsion on Lung Cancer Cells through the Activation of AMP-Activated Protein Kinase Signaling Pathway","volume":"10","author":"Chen","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"11009","DOI":"10.1038\/srep11009","article-title":"EGCG Regulates the Cross-Talk between JWA and Topoisomerase II\u03b1 in Non-Small-Cell Lung Cancer (NSCLC) Cells","volume":"5","author":"Li","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/tox.24475","article-title":"Intervention of a Communication Between PI3K\/Akt and \u03b2-Catenin by (\u2212)-Epigallocatechin-3-Gallate Suppresses TGF-\u03921-Promoted Epithelial-Mesenchymal Transition and Invasive Phenotype of NSCLC Cells","volume":"40","author":"Hsu","year":"2025","journal-title":"Environ. Toxicol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"51","DOI":"10.62347\/BMKT5441","article-title":"Exploring the Effect of Epigallocatechin Gallate on Non Small Cell Lung Cancer","volume":"15","author":"Moar","year":"2024","journal-title":"Int. J. Biochem. Mol. Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"6832","DOI":"10.1021\/acsabm.4c00958","article-title":"Epigallocatechin-3-Gallate Synergistically Inhibits the Proliferation of Lung Cancer Cells with Gemcitabine by Induction of Apoptosis Mediated by ROS Generation","volume":"7","author":"Mishra","year":"2024","journal-title":"ACS Appl. Bio Mater."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4196\/kjpp.2014.18.1.61","article-title":"Reversal of Cisplatin Resistance by Epigallocatechin Gallate Is Mediated by Downregulation of Axl and Tyro 3 Expression in Human Lung Cancer Cells","volume":"18","author":"Kim","year":"2014","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/carcin\/bgt347","article-title":"Synergistic Inhibition of Lung Cancer Cell Lines by (\u2212)-Epigallocatechin-3-Gallate in Combination with Clinically Used Nitrocatechol Inhibitors of Catechol-O-Methyltransferase","volume":"35","author":"Forester","year":"2014","journal-title":"Carcinogenesis"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1271\/bbb.120882","article-title":"Effects of Epigallocatechin-3-Gallate (EGCG) on A549 Lung Cancer Tumor Growth and Angiogenesis","volume":"77","author":"Sakamoto","year":"2013","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"ref_64","first-page":"169","article-title":"Epigallocatechin-3-Gallate Inhibits IGF-I-Stimulated Lung Cancer Angiogenesis through Downregulation of HIF-1\u03b1 and VEGF Expression","volume":"6","author":"Li","year":"2013","journal-title":"J. Nutr. Nutr."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00280-012-2063-z","article-title":"(\u2212)-Epigallocatechin-3-Gallate Inhibits Human Papillomavirus (HPV)-16 Oncoprotein-Induced Angiogenesis in Non-Small Cell Lung Cancer Cells by Targeting HIF-1\u03b1","volume":"71","author":"He","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"8623","DOI":"10.1002\/jcb.27117","article-title":"Epigallocatechin-3-gallate Inhibited Cancer Stem Cell\u2013like Properties by Targeting Hsa-mir-485-5p\/RXR\u03b1 in Lung Cancer","volume":"119","author":"Jiang","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1038\/s41598-020-59281-z","article-title":"(\u2212)-Epigallocatechin Gallate Inhibits Stemness and Tumourigenicity Stimulated by AXL Receptor Tyrosine Kinase in Human Lung Cancer Cells","volume":"10","author":"Namiki","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.3892\/ijmm.2020.4758","article-title":"Epigallocatechin-3-gallate Inhibits Self-renewal Ability of Lung Cancer Stem-like Cells through Inhibition of CLOCK","volume":"46","author":"Jiang","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.1002\/ptr.7990","article-title":"Epigallocatechin Gallate Circumvents Drug-induced Resistance in Non-small-cell Lung Cancer by Modulating Glucose Metabolism and AMPK\/AKT\/MAPK Axis","volume":"37","author":"Zhou","year":"2023","journal-title":"Phytother. Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1158\/1940-6207.CAPR-09-0185","article-title":"Epigallocatechin Gallate Suppresses Lung Cancer Cell Growth through Ras-GTPase-Activating Protein SH3 Domain-Binding Protein 1","volume":"3","author":"Shim","year":"2010","journal-title":"Cancer Prev. Res."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Wang, Y., Shen, X.-J., Su, F.-W., Xie, Y.-R., Wang, L.-X., Zhang, N., Wu, Y.-L., Niu, Y., Zhang, D.-Y., and Zi, C.-T. (2021). Novel Perbutyrylated Glucose Derivatives of (\u2212)-Epigallocatechin-3-Gallate Inhibit Cancer Cells Proliferation by Decreasing Phosphorylation of the EGFR: Synthesis, Cytotoxicity, and Molecular Docking. Molecules, 26.","DOI":"10.3390\/molecules26144361"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1248\/bpb.24.883","article-title":"Modulation of Gene Expression by (\u2212)-Epigallocatechin Gallate in PC-9 Cells Using a cDNA Expression Array","volume":"24","author":"Okabe","year":"2001","journal-title":"Biol. Pharm. Bull."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Rawangkan, A., Wongsirisin, P., Namiki, K., Iida, K., Kobayashi, Y., Shimizu, Y., Fujiki, H., and Suganuma, M. (2018). Green Tea Catechin Is an Alternative Immune Checkpoint Inhibitor That Inhibits PD-L1 Expression and Lung Tumor Growth. Molecules, 23.","DOI":"10.3390\/molecules23082071"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"7970","DOI":"10.1002\/jcp.29451","article-title":"EGCG Regulates CTR1 Expression through Its Pro-oxidative Property in Non-small-cell Lung Cancer Cells","volume":"235","author":"Chen","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1093\/carcin\/bgr218","article-title":"Green Tea Polyphenol EGCG Suppresses Lung Cancer Cell Growth through Upregulating miR-210 Expression Caused by Stabilizing HIF-1\u03b1","volume":"32","author":"Wang","year":"2011","journal-title":"Carcinogenesis"},{"key":"ref_76","first-page":"1509","article-title":"Epigallocatechin-3-gallate Modulates Long Non-coding RNA and mRNA Expression Profiles in Lung Cancer Cells","volume":"19","author":"Hu","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_77","first-page":"2025","article-title":"Promoter Demethylation of WIF-1 by Epigallocatechin-3-Gallate in Lung Cancer Cells","volume":"29","author":"Gao","year":"2009","journal-title":"Anticancer. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e22999","DOI":"10.1002\/jbt.22999","article-title":"Low Dose Epigallocatechin-3-gallate Revives Doxorubicin Responsiveness by a Redox-sensitive Pathway in A549 Lung Adenocarcinoma Cells","volume":"36","author":"Datta","year":"2022","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"ref_79","first-page":"3875","article-title":"Inhibition of Tobacco-Specific Nitrosamine-Induced Lung Tumorigenesis in A\/J Mice by Green Tea and Its Major Polyphenol as Antioxidants","volume":"52","author":"Xu","year":"1992","journal-title":"Cancer Res."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Zhou, H., Chen, J.X., Yang, C.S., Yang, M.Q., Deng, Y., and Wang, H. (2014). Gene Regulation Mediated by microRNAs in Response to Green Tea Polyphenol EGCG in Mouse Lung Cancer. BMC Genom., 15.","DOI":"10.1186\/1471-2164-15-S11-S3"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1007\/s11095-010-0056-3","article-title":"Effect of Dietary Polyphenon E and EGCG on Lung Tumorigenesis in A\/J Mice","volume":"27","author":"Zhang","year":"2010","journal-title":"Pharm. Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3892\/ol.2012.972","article-title":"Role of Ku70 and Bax in Epigallocatechin-3-Gallate-Induced Apoptosis of A549 Cells In Vivo","volume":"5","author":"Li","year":"2013","journal-title":"Oncol. Lett."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1093\/jn\/136.7.1839","article-title":"Tea Polyphenols and Theaflavins Are Present in Prostate Tissue of Humans and Mice after Green and Black Tea Consumption","volume":"136","author":"Henning","year":"2006","journal-title":"J. Nutr."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1093\/jn\/133.12.4172","article-title":"Epigallocatechin-3-Gallate Is Absorbed but Extensively Glucuronidated Following Oral Administration to Mice","volume":"133","author":"Lambert","year":"2003","journal-title":"J. Nutr."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1124\/dmd.104.003434","article-title":"Dose-Dependent Levels of Epigallocatechin-3-Gallate in Human Colon Cancer Cells and Mouse Plasma and Tissues","volume":"34","author":"Lambert","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/147323000303100205","article-title":"A Single Ascending Dose Study of Epigallocatechin Gallate in Healthy Volunteers","volume":"31","author":"Ullmann","year":"2003","journal-title":"J. Int. Med. Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1024\/0300-9831.74.4.269","article-title":"Plasma-Kinetic Characteristics of Purified and Isolated Green Tea Catechin Epigallocatechin Gallate (EGCG) after 10 Days Repeated Dosing in Healthy Volunteers","volume":"74","author":"Ullmann","year":"2004","journal-title":"Int. J. Vitam. Nutr. Res."},{"key":"ref_88","first-page":"351","article-title":"Blood and Urine Levels of Tea Catechins after Ingestion of Different Amounts of Green Tea by Human Volunteers","volume":"7","author":"Yang","year":"1998","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_89","first-page":"3312","article-title":"Pharmacokinetics and Safety of Green Tea Polyphenols after Multiple-Dose Administration of Epigallocatechin Gallate and Polyphenon E in Healthy Individuals","volume":"9","author":"Chow","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1080\/00498250110079149","article-title":"Plasma Concentrations of Individual Tea Catechins after a Single Oral Dose in Humans","volume":"31","author":"Mathot","year":"2001","journal-title":"Xenobiotica"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1271\/bbb.61.1981","article-title":"Dose-Dependent Incorporation of Tea Catechins, (\u2212)-Epigallocatechin-3-Gallate and (\u2212)-Epigallocatechin, into Human Plasma","volume":"61","author":"Nakagawa","year":"1997","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"ref_92","first-page":"1025","article-title":"Pharmacokinetics of Tea Catechins after Ingestion of Green Tea and (\u2212)-Epigallocatechin-3-Gallate by Humans: Formation of Different Metabolites and Individual Variability","volume":"11","author":"Lee","year":"2002","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1017\/S0007114510002709","article-title":"Plasma Appearance and Correlation between Coffee and Green Tea Metabolites in Human Subjects","volume":"104","author":"Renouf","year":"2010","journal-title":"Br. J. Nutr."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1158\/1940-6207.CAPR-16-0298","article-title":"A Presurgical Study of Lecithin Formulation of Green Tea Extract in Women with Early Breast Cancer","volume":"10","author":"Lazzeroni","year":"2017","journal-title":"Cancer Prev. Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"100037","DOI":"10.1016\/j.focha.2022.100037","article-title":"Approaches to Overcome Bioavailability Inconsistencies of Epigallocatechin Gallate, a Powerful Anti-Oxidant in Green Tea","volume":"1","author":"Furniturewalla","year":"2022","journal-title":"Food Chem. Adv."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.radonc.2013.10.014","article-title":"A Phase I Study of Concurrent Chemotherapy and Thoracic Radiotherapy with Oral Epigallocatechin-3-Gallate Protection in Patients with Locally Advanced Stage III Non-Small-Cell Lung Cancer","volume":"110","author":"Zhao","year":"2014","journal-title":"Radiother. Oncol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.radonc.2015.02.014","article-title":"A Prospective Phase II Trial of EGCG in Treatment of Acute Radiation-Induced Esophagitis for Stage III Lung Cancer","volume":"114","author":"Zhao","year":"2015","journal-title":"Radiother. Oncol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.radonc.2019.02.022","article-title":"A Prospective, Three-Arm, Randomized Trial of EGCG for Preventing Radiation-Induced Esophagitis in Lung Cancer Patients Receiving Radiotherapy","volume":"137","author":"Zhao","year":"2019","journal-title":"Radiother. Oncol."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/3\/378\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T05:21:56Z","timestamp":1769750516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/3\/378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":98,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["nu18030378"],"URL":"https:\/\/doi.org\/10.3390\/nu18030378","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]}}}